TrialArthritis and rheumatism2011

Subcutaneous abatacept versus intravenous abatacept: a phase IIIb noninferiority study in patients with an inadequate response to methotrexate.

M C Genovese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.